Results for tag: "Vascular Disrupting Agent"

Vascular Disrupting Agents (VDAs) are a class of drugs used to treat cardiovascular diseases. They work by disrupting the blood vessels that supply oxygen and nutrients to the heart, leading to a decrease in the size of the affected area. VDAs are used to treat conditions such as coronary artery disease, peripheral artery disease, and stroke. They can also be used to reduce the risk of heart attack and stroke. VDAs are typically administered intravenously or orally. They are usually given in combination with other drugs, such as antiplatelet agents, anticoagulants, and statins. The most common side effects of VDAs include nausea, vomiting, and diarrhea. The Vascular Disrupting Agent market is a rapidly growing segment of the cardiovascular drugs market. It is expected to continue to grow as more drugs are developed and approved for use. Some companies in the Vascular Disrupting Agent market include AstraZeneca, Merck, Pfizer, and Novartis. Show Less Read more